The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway

CC Tomlinson, B Damania - Journal of virology, 2004 - Am Soc Microbiol
CC Tomlinson, B Damania
Journal of virology, 2004Am Soc Microbiol
Kaposi's sarcoma-associated herpesvirus (KSHV) has been implicated in Kaposi's sarcoma,
as well as in primary effusion lymphoma and multicentric Castleman's disease. The K1
protein of KSHV has been shown to induce cellular transformation and focus formation and
to deregulate B-lymphocyte signaling pathways by functionally mimicking the activated B-
cell receptor complex. Here we show that expression of K1 in B lymphocytes targets the
phosphatidylinositol-3 kinase pathway, leading to the activation of the Akt kinase and the …
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) has been implicated in Kaposi's sarcoma, as well as in primary effusion lymphoma and multicentric Castleman's disease. The K1 protein of KSHV has been shown to induce cellular transformation and focus formation and to deregulate B-lymphocyte signaling pathways by functionally mimicking the activated B-cell receptor complex. Here we show that expression of K1 in B lymphocytes targets the phosphatidylinositol-3 kinase pathway, leading to the activation of the Akt kinase and the inhibition of the phosphatase PTEN. We also demonstrate that activation of Akt by the K1 protein leads to the phosphorylation and inhibition of members of the forkhead (FKHR) transcription factor family, which are key regulators of cell cycle progression and apoptosis. We demonstrate that K1 can inhibit apoptosis induced by the FKHR proteins and by stimulation of the Fas receptor. Our observations suggest that the K1 viral protein promotes cell survival pathways and may contribute to KSHV pathogenesis by preventing virally infected cells from undergoing apoptosis prematurely.
American Society for Microbiology